- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04887428
Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD) (PROMICI)
The main objective of this project is to assess the occupational insertion of these adult patients with pediatric-onset IBD and to compare it with the general population.
The secondary objectives are:
- to assess the level of education and compare it to that of the general population
to assess occupational insertion and the educational level according to:
- The disease (Crohn's disease, ulcerative colitis or unclassified colitis)
- sex
- Age at diagnosis (<or ≥ 10 years)
- The occurence of surgery, the location of the disease, the treatments undertaken
- Quality of life
- Evaluate the patient's feelings about the impact of his illness on occupational insertion and the educational level
- To describe the quality of life of patients in relation to disease activity and health states (QALY calculation)
- To assess the responsivness to change of the functional handicap score IBD-DI (n = 200 patients)
Study Overview
Status
Conditions
Detailed Description
Chronic inflammatory bowel diseases (IBD) are responsible for high morbidity and impaired quality of life of patients throughout disease course.
Numerous studies have shown the impact of the disease on the quality of life of patients with IBD. However, very little data is available on the level of education and professional integration of patients who started their IBD in childhood.
The hypothesis behind the study project is that the level of education and consequently the professional integration of patients with early pediatric IBD: 1) could be different from those of the general population; 2) and that these differences could be influenced by the nature of IBD, the age of its onset and its main characteristics.
The main objective of this project is to assess the professional integration of these adult patients with pediatric-onset IBD and to compare it with the general population.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lille, France, 59037
- Hop Jeanne de Flandre Chu Lille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female, aged 25 and over at the time of the study
- Subject listed in the EPIMAD registry suffering from certain or probable Crohn's disease, or certain or probable ulcerative colitis, or certain or probable ulcerated proctitis, unclassified colitis, diagnosed between 01/01 / 1988 and 12/31/2011, with an age at diagnosis of less than 17 years (definition of the pediatric cohort of the EPIMAD Registry)
- Patient residing in the area of the EPIMAD registry: Nord, Pas-de-Calais, Somme or Seine-Maritime
- Patient not opposed to the research
- Patient not having objected to the use of their data for ancillary studies when registering in the EPIMAD register
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of active workers in employment
Time Frame: through study completion, an average of 18 months
|
Rate of active workers in employment collected using a standardized self-questionnaire
|
through study completion, an average of 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Educational level
Time Frame: through study completion, an average of 18 months
|
Description of educational level collected using a standardized self-administered questionnaire
|
through study completion, an average of 18 months
|
|
Association between occupational insertion and disease variables
Time Frame: through study completion, an average of 18 months
|
Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis
|
through study completion, an average of 18 months
|
|
Association between occupational insertion and quality of life
Time Frame: through study completion, an average of 18 months
|
Quality of life as measured by SIBDQ questionnaire.
|
through study completion, an average of 18 months
|
|
Association between educational level and disease variables
Time Frame: through study completion, an average of 18 months
|
Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis
|
through study completion, an average of 18 months
|
|
Association between educational level and quality of life
Time Frame: through study completion, an average of 18 months
|
Quality of life as measured by SIBDQ questionnaire.
|
through study completion, an average of 18 months
|
|
Percentage of patients for whom the disease had an influence on the choice of studies
Time Frame: through study completion, an average of 18 months
|
This question is directly asked to the patient and reflects its own feeling
|
through study completion, an average of 18 months
|
|
Percentage of patients for whom the disease had an influence on the course of the studies
Time Frame: through study completion, an average of 18 months
|
This question is directly asked to the patient and reflects its own feeling
|
through study completion, an average of 18 months
|
|
Percentage of patients for whom the disease had an influence on the choice of profession
Time Frame: through study completion, an average of 18 months
|
This question is directly asked to the patient and reflects its own feeling
|
through study completion, an average of 18 months
|
|
Quality of life as measured by EQ5D-5L questionnaire
Time Frame: through study completion, an average of 18 months
|
Quality of life as measured by EQ5D-5L questionnaire and transformed into utility according to French reference values.
Quality of life will be described according to age, disease activity and surgery.
|
through study completion, an average of 18 months
|
|
Disease activity for Crohn's patients
Time Frame: through study completion, an average of 18 months
|
As measured by HBI (Harvey-Bradshaw Index).
Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index.
|
through study completion, an average of 18 months
|
|
Disease activity for Ulcerative Colitis patients
Time Frame: through study completion, an average of 18 months
|
As measured by SCCAI questionnaire (Simple Clinical Colitis Activity Index).
Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index.
|
through study completion, an average of 18 months
|
|
Disability in 200 patients
Time Frame: through study completion, an average of 18 months
|
As measured by IBD-DI (IBD Disability Index) in 200 patients previously questioned in 2012 in order to address the question of sensitivity to change of IBD-DI.
Measure of change is disease activity as measured by HBI-Index for Crohn's patients and SCCAI for Ulcerative Colitis patients.
|
through study completion, an average of 18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dominique Turck, MD,PhD, University Hospital, Lille
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017_19
- 2017-A03397-46 (Other Identifier: ID-RCB number, ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Crohn Disease
-
Turku University HospitalUniversity of TurkuRecruitingInflammatory Bowel Diseases | Crohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn Disease in Remission | Crohn Disease of Small IntestineFinland
-
Tzaneio General HospitalRecruitingCrohn Disease (CD) | Crohn Disease of Ileum | Kono S Anastomosis | Extended Mesenteric ExcisionGreece
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.Not yet recruitingCrohn&Amp;#39;s | Crohn&Amp;#39;s Disease (CD)
-
Shmuel Kivity, MDRecruiting
-
University Hospital, Clermont-FerrandNot yet recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingCrohn Disease (CD)France
-
GLSMED Learning Health S.A.Not yet recruiting
-
University Hospital, Clermont-FerrandActive, not recruiting
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Direct Biologics, LLCNot yet recruiting